Compositions comprising osteopontin (opn)
AssigneeSociete des Produits Nestle S.A.
InventorsELIZABETH FORBES-BLOM, MARIO NOTI, CHEONG KWET CHOY KWONG CHUNG
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising osteopontin (OPN) for the treatment and/or prevention of viral infections in mammals, such as humans, in particular infants, young children and pre-schoolers.
Claims23
A method for the treatment and/or prevention of a viral infection in a mammal comprising administering a composition comprising osteopontin (OPN) to the mammal.
(canceled)
(canceled)
(canceled)
(canceled)
A method for use in preventing or reducing the risk of allergen sensitisation and/or developing an allergic respiratory tract disease in a mammal comprising administering osteopontin (OPN) to the mammal.
A method for use in preventing or reducing the risk of pulmonary diseases, including chronic obstructive pulmonary disease, in a mammal comprising administering osteopontin (OPN) to the mammal.
(canceled)
Dependencies are inferred from the claim text.